Patient Analytics & Journey Mapping
We map how patients move from symptom to diagnosis to treatment — identifying diagnostic delays, treatment gaps, and drop-off points that represent both commercial opportunity and patient outcome risks. Analysis draws on real-world claims and EMR data, validated with primary research where needed.
Patient Finder & Activation Analytics
Finding the right patients at the right time is critical in specialty and rare disease. We design patient finder models that identify HCPs treating patients of interest, accurately size treatable populations, and inform field prioritisation and hub engagement strategies.
Real-World Data Strategy & Analysis
We design and execute commercial analyses on claims, EMR, and specialty data — including source-of-business analysis, treatment pattern assessments, persistency and adherence studies, and outcomes analyses that support both commercial and payer-facing objectives.
Forecasting & Scenario Modelling
We build market sizing, brand forecasting, and scenario analysis frameworks that support investment decisions, BD&L evaluations, and board presentations. Work spans epidemiology-based forecasting for novel assets through to in-market brand forecasts with promotional response modelling.
Commercial Performance Dashboards
We design and implement the performance monitoring infrastructure that gives brand teams and sales leadership a single, reliable view of what is working — integrating sales, field activity, market access, and patient-level data into dashboards built for decision speed, not reporting compliance.
Competitive Intelligence
Continuous monitoring and structured analysis of the competitive landscape — including pipeline tracking, promotional activity assessment, payer coverage benchmarking, and scientific communication analysis — structured as an ongoing intelligence function rather than a periodic research exercise.
Market Research Design & Synthesis
We design and manage primary research programmes across HCP, patient, and payer audiences — qualitative and quantitative — and synthesise findings into commercial recommendations rather than slide decks of verbatim quotes.